CN Patent

CN103998041A — 新的药物组合物

Assigned to Nova Laboratories Sdn Bhd · Expires 2014-08-20 · 12y expired

What this patent protects

本发明涉及新的包含N-{3-[3-环丙基-5-(2-氟-4-碘-苯基氨基)-6,8-二甲基-2,4,7-三氧代-3,4,6,7-四氢-2H-吡啶并[4,3-d]嘧啶-1-基]苯基}乙酰胺二甲基亚砜溶剂合物的药物组合物、在治疗中使用该组合物的方法以及制备该组合物的方法。

USPTO Abstract

本发明涉及新的包含N-{3-[3-环丙基-5-(2-氟-4-碘-苯基氨基)-6,8-二甲基-2,4,7-三氧代-3,4,6,7-四氢-2H-吡啶并[4,3-d]嘧啶-1-基]苯基}乙酰胺二甲基亚砜溶剂合物的药物组合物、在治疗中使用该组合物的方法以及制备该组合物的方法。

Drugs covered by this patent

trametinib-dimethyl-sulfoxide (TRAMETINIB DIMETHYL SULFOXIDE)

Patent Metadata

Patent number: CN103998041A
Jurisdiction: CN
Classification: —
Expires: 2014-08-20
Drug substance claim: No
Drug product claim: No
Assignee: Nova Laboratories Sdn Bhd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.